K. A. Hill

Intensive versus moderate lipid lowering with statins after acute coronary syndromes.

Christopher P Cannon, Marc A Pfeffer, A. Skene, 2004, The New England journal of medicine.

Comparison of intensive and moderate lipid lowering with statins after acute coronary symptoms

A. Skene, M. Pfeffer, J. Rouleau, 2004 .

Creatine metabolism in the pyridoxine-deficient rat.

G. Loo, J. Smith, K. A. Hill, 1986, The Journal of nutrition.

LY2928057, An Antibody Targeting Ferroportin, Is a Potent Inhibitor Of Hepcidin Activity and Increases Iron Mobilization In Normal Cynomolgus Monkeys

V. Wroblewski, J. Manetta, D. Leung, 2013 .

Cardiovascular findings in arterial tortuosity syndrome

C. Cannon, C. McCabe, J. López-Sendón, 2015 .

Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation.

A. Skene, M. Sabatine, E. Braunwald, 2005, The New England journal of medicine.

Comparison of intensive and moderate lipid lowering with statins after acute coronary symptoms

A. Skene, M. Pfeffer, J. Rouleau, 2004 .

Intensive versus moderate lipid lowering with statins after acute coronary syndromes.

E. Braunwald, K. A. Hill, Daniel J. Rader, 2004, The New England journal of medicine.